Table 1.
Age [mean (SD)] | 49 (11.5) |
Menopausal status [n (%)] | |
Pre | 40 (44.4%) |
Post | 50 (55.6%) |
Clinical stage [n (%)] | |
II | 44 (48.9%) |
III | 46 (51.1%) |
Histology [n (%)] | |
Ductal | 80 (88.9%) |
Others | 10 (11.1%) |
Grade [n (%)] | |
1 | 16 (17.8%) |
2 | 52 (57.8%) |
3 | 22 (24.4%) |
ER positive [n (%)] | 57 (63.3%) |
PgR positive [n (%)] | 39 (43.3%) |
HER2 positive [n (%)] | 25 (27.7%) |
Objective response [n (%)] | 72 (80%) |
Breast-conserving surgery rate [n (%)] | 47 (52.8%) |
pCR [n (%)] | 11 (12.2%) |
Negative ALN [n (%)] | 38 (42%) |
ER, estrogen receptor; PgR, progesterone receptor; pCR, complete pathological response; ALN, axillary lymph node.